FIGURE 5.
Violin plot contrasting change in monthly migraine days (MMD) after 3 months of treatment with erenumab in patients who had had medication overuse (MO) or not (non‐MO) at baseline
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.